Genome Research and Traditional Intellectual Property Protection -- A Bad Fit?

Dr. Murashige addresses the need for a patent system more closely tailored to the needs of biotechnology. For example, the obviousness requirement may interfere with using patents to recoup high costs of work when it could arguably be done by researchers of ordinary skill

Overview of Potential Intellectual Property Protection for Biotechnology

Dr. Murashige compares the function and value of copyright, patent and trade secret laws in recovering investments in developing genome-related biotechnology